belantamab mafodotin: a potential new soc in second-line myeloma based on the dreamm trials
Published 4 months ago • 63 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:44
the role of belantamab mafodotin in multiple myeloma: the dreamm-7 and dreamm-8 trials
-
0:48
final analysis of the dreamm-2 trial: belantamab mafodotin for r/r multiple myeloma
-
2:16
findings from dreamm-7 establish belantamab mafodotin as a new soc for r/r multiple myeloma
-
3:00
results of a phase i study of belantamab mafodotin in combination with krd for treating myeloma
-
1:32
the use of belantamab mafodotin in triplet combinations for multiple myeloma
-
2:15
results of dreamm-4: safety and efficacy of belantamab mafodotin with pembrolizumab in r/r myeloma
-
1:20
the role of belantamab mafodotin in myeloma treatment and managing the associated ocular toxicities
-
1:33
the potential role of belantamab mafodotin in multiple myeloma
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
2:24
what is the current status of belantamab and its potential reapproval?
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:59
dreamm-2: update on belantamab mafodotin in r/r myeloma
-
1:36
dreamm-2: belantamab mafodotin for r/r myeloma
-
5:15
dreamm-2 & dreamm-5: belantamab mafodotin for myeloma
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
3:04
dreamm-3: belantamab mafodotin vs pom/dex for r/r myeloma
-
1:02
dreamm-3: safety of belantamab mafodotin versus pom/dex in patients with r/r myeloma
-
2:11
belantamab mafodotin for multiple myeloma | nejm
-
1:16
treatment combinations being explored with belantamab mafodotin in multiple myeloma
-
1:51
an update on the use of belantamab mafodotin in multiple myeloma
-
2:05
belantamab mafodotin combined with lenalidomide and dexamethasone in r/r mm: insights from dreamm-6
-
3:29
belantamab mafodotin in myeloma: advantages and disadvantages